Biomea Fusion Inc.
Clinical trials sponsored by Biomea Fusion Inc., explained in plain language.
-
New diabetes pill shows promise for patients stuck on ozempic
Disease control Recruiting nowThis study tests a new daily pill, icovamenib, for people with type 2 diabetes who still have high blood sugar despite taking Ozempic. About 60 adults will receive either the pill or a placebo for 12 weeks. The main goal is to see if the pill lowers HbA1c (a measure of blood suga…
Phase: PHASE2 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New diabetes pill icovamenib enters Mid-Stage trial
Disease control Recruiting nowThis Phase 2 trial tests whether a new drug called icovamenib can help people with type 2 diabetes who still have high blood sugar despite taking other medications. About 60 adults aged 18 to 70 will receive either icovamenib or a placebo daily for 12 weeks. The main goal is to s…
Phase: PHASE2 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC